Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms

Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents

(2018) Leigh Goedeke et al.   HEPATOLOGY

Naringin attenuates alcoholic liver injury by reducing lipid accumulation and oxidative stress

(2018) Chuying Zhou et al.   LIFE SCIENCES

Establishment of an ex Vivo Model of Nonalcoholic Fatty Liver Disease Using a Tissue-Engineered Liver

(2018) Qiao Wu et al.   ACS Biomaterials-Science & Engineering

Establishment of an ex Vivo Model of Nonalcoholic Fatty Liver Disease Using a Tissue-Engineered Liver

(2018) Qiao Wu et al.   ACS Biomaterials Science & Engineering

Trimming the Fat: Acetyl-CoA Carboxylase Inhibition for the Management of NAFLD

(2018) Norihiro Imai et al.   HEPATOLOGY

Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis

(2018) Zobair Younossi et al.   HEPATOLOGY

Naringin in Ganshuang Granule suppresses activation of hepatic stellate cells for anti-fibrosis effect by inhibition of mammalian target of rapamycin

(2016) Hongbo Shi et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Amelioration of nonalcoholic fatty liver disease by hepatic stimulator substance via preservation of carnitine palmitoyl transferase-1 activity

(2015) Weichun Xiao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Flavonoids and Related Compounds in Non-Alcoholic Fatty Liver Disease Therapy

(2015) Sandra Pisonero-Vaquero et al.   CURRENT MEDICINAL CHEMISTRY

Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD

(2015) Michael Allison et al.   SEMINARS IN LIVER DISEASE

Prevalence of fatty liver disease and the economy in China: A systematic review

(2015) Jin-Zhou Zhu   WORLD JOURNAL OF GASTROENTEROLOGY

Physiological Functions of Peroxisome Proliferator-Activated Receptor β

(2014) Jaap G. Neels et al.   PHYSIOLOGICAL REVIEWS

Effect of Citrus Flavonoids, Naringin and Naringenin, on Metabolic Syndrome and Their Mechanisms of Action

(2014) M. Ashraful Alam et al.   Advances in Nutrition

CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis inob/obmice

(2013) Fatiha Nassir et al.   JOURNAL OF LIPID RESEARCH

Naringin Improves Diet-Induced Cardiovascular Dysfunction and Obesity in High Carbohydrate, High Fat Diet-Fed Rats

(2013) Md. Alam et al.   Nutrients

Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C

(2011) M. E. Miquilena-Colina et al.   GUT

Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds

(2010) Yunfang Wang et al.   HEPATOLOGY

Naringenin enhances insulin-stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome

(2009) Sriramajayam Kannappan et al.   EUROPEAN JOURNAL OF NUTRITION

Nonsynonymous Mutations withinAPOBin Human Familial Hypobetalipoproteinemia

(2009) Shumei Zhong et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Fatty liver, insulin resistance, and dyslipidemia

(2008) Martin Adiels et al.   Current Diabetes Reports

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

(2008) Catherine Postic et al.   JOURNAL OF CLINICAL INVESTIGATION

The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism

(2008) Henry N. Ginsberg et al.   JOURNAL OF LIPID RESEARCH

Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)

(2008) G MUSSO et al.   PROGRESS IN LIPID RESEARCH

Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease

(2007) Elisa Fabbrini et al.   GASTROENTEROLOGY